Abstract

The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.

Details

Title
Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
Author
Park, Tae-Eun 1   VIAFID ORCID Logo  ; Mustafaoglu, Nur 2 ; Herland, Anna 3 ; Hasselkus, Ryan 2   VIAFID ORCID Logo  ; Mannix, Robert 4 ; FitzGerald, Edward A 2   VIAFID ORCID Logo  ; Prantil-Baun, Rachelle 2 ; Watters, Alexander 2 ; Henry, Olivier 2 ; Benz, Maximilian 2   VIAFID ORCID Logo  ; Sanchez, Henry 2 ; McCrea, Heather J 5 ; Goumnerova, Liliana Christova 5   VIAFID ORCID Logo  ; Song, Hannah W 6 ; Palecek, Sean P 6 ; Shusta, Eric 6 ; Ingber, Donald E 7   VIAFID ORCID Logo 

 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA; Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea 
 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA 
 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA; Division of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden; Swedish Medical Nanoscience Center, Department of Neuroscience, Karolinska Institute, Stockholm, Sweden 
 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA; Vascular Biology Program and Department of Surgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA 
 Department of Neurosurgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA 
 Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA 
 Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA; Vascular Biology Program and Department of Surgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA 
Pages
1-12
Publication year
2019
Publication date
Jun 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2239631445
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.